Niagen Bioscience Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	330	392	97	117	225	243
Market Cap Growth	-20.98%	302.70%	-17.00%	-47.82%	-7.52%	6.28%
Enterprise Value	279	364	77	109	199	232
Last Close Price	3.96	5.20	1.32	1.49	3.26	3.88
PE Ratio	18.97	47.50	-	-	-	-
PS Ratio	3.11	4.08	1.29	1.74	3.79	5.02
PB Ratio	5.48	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	5.50	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	18.33	33.99	15.45	-	-	-
P/OCF Ratio	18.11	33.54	15.13	-	-	-
EV/Sales Ratio	2.63	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	15.34	44.12	-	-	-	-
EV/EBIT Ratio	17.00	48.76	-	-	-	-
EV/FCF Ratio	15.45	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Net Debt / Equity Ratio	-0.86	-0.91	-0.84	-0.56	-0.73	-0.90
Net Debt / EBITDA Ratio	-3.04	-4.90	5.23	0.91	0.90	0.79
Net Debt / FCF Ratio	-2.89	-3.50	-3.43	1.04	0.95	1.39
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Invested Capital (ROIC)	221.46%	169.60%	-65.11%	-176.99%	-542.87%	-776.15%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	5.27%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	5.46%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.